Robotic Rehabilitation in Patients With Acute Stroke

Summary

The advantage of the EMG-driven exoskeletons is that patient's own muscle power known as Residual Muscle Power is used to move the extremity while many other robotic devices work and drive impaired limb based on machine directed force. However, it is not clear which group of patients are suitable for EMG driven exoskeletons use and there has not been any established treatment protocol.

The aims of the study are 1- to investigate the effectiveness of the EMG-driven exoskeleton for hand rehabilitation in patients with acute stroke. 2- to understand which group of the patients may give the best response to the EMG-driven technology and how should be the treatment protocol designed.

Conditions

• Acute Stroke

Interventions

DEVICE

EMG-driven exoskeleton hand robot

Primary Outcome Measurement: 1\. Fugl-Meyer Upper Extremity Assessment Secondary Outcome Measurements: 1. Action Research Arm Test 2. Motor Activity Log 3. Data from force and EMG measurement records of HOH robot 4. Grip strength (with hand dynamometer) 5. Range of motion measurements of Wrist, and MCP, PIP and DIP joints of the fingers 6. Manuel muscle testing for wrist and finger muscles. 7. Modify Asworth sclale At the beginning of each robotic treatment session, superficial EMG recording will be taken at relax position ( without muscle contraction) and then during maximal voluntary isometric contraction (MVC) after the patient's hand is placed in the exoskeleton. For both, EMG recording is performed for 7 seconds and Root Mean Square (RMS) is calculated from this record.

OTHER

Conventional physiotherapy

Primary Outcome Measurement: 1\. Fugl-Meyer Upper Extremity Assessment Secondary Outcome Measurements: 1. Action Research Arm Test 2. Motor Activity Log 3. Data from force and EMG measurement records of HOH robot 4. Grip strength (with hand dynamometer) 5. Range of motion measurements of Wrist, and MCP, PIP and DIP joints of the fingers 6. Manuel muscle testing for wrist and finger muscles. 7. Modify Asworth sclale

Sponsors & Collaborators

• Medipol University

  collaborator OTHER

• Medical Park Hospital Istanbul

  collaborator OTHER

• Rehab-Robotics Company Limited

  collaborator INDUSTRY

• Bahçeşehir University

  lead OTHER

Principal Investigators

• Dilber Karagozoglu Coskunsu, Ass.Prof. · Bahçeşehir University

• Sumeyye Akcay, PT · Bahçeşehir University

• Özden Erkan Oğul, Ass.Prof. · Medipol University

• Kubra Yıldırım, PT · IAU Medical Park Florya Hospital

• Yakup Krespi, Prof. · IAU Medical Park Florya Hospital

• Haris Begovic, PhD · Hong Kong Polytechnic University

• Necla Öztürk, Prof. · Maltepe University

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-04-06

Primary Completion

2020-03-31

Completion

2020-05-31

Countries

• Turkey (Türkiye)

Study Locations